Last reviewed · How we verify
Lasilactone
At a glance
| Generic name | Lasilactone |
|---|---|
| Also known as | Spironolactone 100 mg plus Furosemide 20 mg |
| Sponsor | Hospital de Clinicas de Porto Alegre |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices (NA)
- Management of Decompensated HCV Cirrhotic Patients (NA)
- Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |